Specialist Medical Review Council Declaration: Statements of Principles Nos. 69 and 70 of 2012 concerning Myeloma

Overview

The Specialist Medical Review Council Declaration Section 196W of the Veterans’ Entitlements Act 1986 addresses the insufficiency of medical-scientific evidence to amend certain Statements of Principles concerning myeloma and death from myeloma. Enacted by the Parliament of Australia, the Act was introduced to ensure that veterans’ health claims are assessed with the most current and reliable medical-scientific evidence. The Council, under subsection 196W of the VEA, has determined that while there is sufficient evidence to warrant amendments to the Statements of Principles, the current evidence does not support the inclusion of new factors in the same terms as existing factors. Consequently, the Council directs the Repatriation Medical Authority to amend the Statements of Principles to include a specific factor related to exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD) before the onset of myeloma. This decision aims to ensure that veterans’ claims are evaluated with due consideration of the latest medical-scientific understanding.

Scope and Application

The Specialist Medical Review Council Declaration under Section 196W of the Veterans' Entitlements Act 1986 pertains to the Statements of Principles Nos. 69 and 70 of 2012, which concern myeloma and death from myeloma. This declaration applies to the Repatriation Medical Authority and the Council itself, aiming to evaluate the medical-scientific evidence related to these statements. The application of this Act is specific to veterans and their entitlements, focusing on medical conditions linked to service, particularly myeloma. The declaration and subsequent directives are applicable across the Commonwealth of Australia, as the Veterans' Entitlements Act 1986 is a federal statute. The Council’s decision also extends to the amendment of Statements of Principles based on the available evidence, thus influencing the eligibility criteria for veterans' benefits. Notably, the declaration does not cover other diseases or conditions not specified within the scope of Statements of Principles Nos. 69 and 70. Furthermore, the application of this Act may be further defined or extended through subordinate legislation or regulations, which can provide additional specifics on the implementation of the Council's directives.

Key Provisions

The Specialist Medical Review Council (SMR Council) under section 196W of the Veterans' Entitlements Act 1986 (VEA) has declared that the medical-scientific evidence available to the Repatriation Medical Authority (RMA) is insufficient to amend Statement of Principles No. 70 of 2012 concerning myeloma and death from myeloma to include factors similar to those in Statement of Principles No. 69 of 2012. The Council has further declared that there is sufficient sound medical-scientific evidence for the RMA to amend both Statements of Principles Nos. 69 and 70 of 2012 by including a specific factor. This factor is exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD), with an expected initial serum TCDD level of at least 1500 parts per trillion before the clinical onset of myeloma. The SMR Council imposes a clear obligation on the RMA to amend both Statement of Principles Nos. 69 and 70 of 2012 as directed. The RMA must incorporate the specific factor related to exposure to TCDD into the criteria for assessing claims related to myeloma and death from myeloma. This directive is grounded in the Council's determination that there is sound medical-scientific evidence to support such an amendment. The Council's role is to ensure that the Statements of Principles reflect the most current and accurate medical understanding, thereby affecting the eligibility criteria for veterans' entitlements. Under the VEA, failure to comply with the Council's directives may result in legal consequences. Although the specific penalties for non-compliance are not outlined in the declaration, the general framework of the VEA implies that breaches could lead to civil or administrative penalties. Such penalties could include fines or other enforcement actions aimed at ensuring adherence to the Council's determinations. The Council's decisions are binding, and non-compliance could potentially impact the validity of claims made under the VEA.